Increasing patient attendance in a pediatric obesity clinic: a quality improvement project

Betty Geer1, Renee M Porter2, Matthew Haemer2

  • 1University of Colorado Anschutz Medical Campus, College of Nursing, Aurora, CO.

Journal of Pediatric Nursing
|September 25, 2014
PubMed

Insights

Intensive lifestyle interventions are key for childhood obesity treatment. Simple, low-cost methods significantly boosted patient attendance in a pediatric obesity clinic, improving follow-up rates.

Area of Science:

  • Pediatrics
  • Public Health
  • Health Services Research

Background:

  • Intensive lifestyle interventions are effective for treating childhood obesity.
  • Patient retention is crucial for the success of these interventions.
  • Childhood obesity requires effective strategies to ensure long-term patient engagement.

Purpose of the Study:

  • To improve patient retention in a pediatric obesity clinic.
  • To increase follow-up attendance rates by 10% through a quality improvement project.
  • To identify effective strategies for enhancing patient adherence in childhood obesity treatment programs.

Main Methods:

  • A pretest-posttest design was employed to evaluate the intervention's impact.
  • Data collection included three months of baseline followed by 52 weeks of intervention data.
  • Descriptive statistics and Fisher's exact test were used for data analysis.

Main Results:

  • Follow-up patient attendance increased significantly from 69% to 81%.
  • The observed improvement in attendance was statistically significant (z=1.76, p=.039).
  • The quality improvement project demonstrated a measurable increase in patient engagement.

Conclusions:

  • Simple and inexpensive interventions can substantially improve attendance rates for obese children.
  • Effective strategies exist to enhance patient follow-up in childhood obesity clinics.
  • Quality improvement initiatives can lead to significant positive outcomes in pediatric obesity management.

Related Concept Videos

Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
361
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.5K
Patient-centered Care01:13

Patient-centered Care

Patient-centered care involves delivering care beyond inpatient hospitalization. Reflective practice can enhance a patient-centered approach. Reflective practice is a process of reasoning that considers all aspects of the present situation, including practicalities, learning from personal practice, and consideration of patient needs. Patients appreciate care decisions made while considering their input. Involving the patient in their care provides the patient with a sense of contribution rather...
3.1K
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
431